Artisan Partners

Artisan Partners Non-U.S. Small-Mid Growth Strategy

International Mid-cap Growth

Dec 2025 → Sep 2026

Our archive holds 4 letters from this strategy, behind 25 investment theses and positions in 33 companies. Every quote below is copied verbatim from the letter it came from.

4 letters in 2 years · follow all of Artisan Partners for every strategy.

Performance

as of Sep 30, 2026 · net of fees · USD · Composite Net

  • YTD
    +8.9%
    index +12.4%
  • 1Y
    +12.0%
    index +16.0%
  • 3Y · /yr
    +12.8%
    index +18.7%
  • 5Y · /yr
    +1.6%
    index +7.4%
  • Inception · /yr
    +10.0%
    index +10.3%

Index: MSCI All Country World ex USA SMID Index

Calendar years

  • 2025
    +18.6%
  • 2024
    −0.1%
  • 2023
    +11.3%
  • 2022
    −23.8%
  • 2021
    +4.1%
Disclaimer

These figures are copied from the manager’s latest letter, as of Sep 30, 2026. They were extracted automatically, have not been verified by HF Best Ideas and may contain errors. They cover a single share class, in the currency and fee basis stated above; other share classes and your own returns will differ. This is not investment advice, nor an offer to buy or sell any fund. Past performance does not predict future returns.

Read full disclosures →

What it bought and sold

  • ExitedLegend BiotechSep 2026
    While our assessment of the company's business fundamentals has proven correct and we remain confident in the commercial potential of Legend’s drug portfolio, we exited our position due to corporate governance concerns.
  • ExitedRotork PLCJun 2026
    (Note that ABB acquired Rotork post the close of Q2 at a 73% premium.)
  • ExitedFabrinetJun 2026
    and former portfolio holding Fabrinet (sold in Q1 on valuation after a nearly six-fold appreciation since our initial investment in August 2020).

Also held

Its investment theses

Every letter